Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03148639

Virtual Reality Therapy for Treatment-resistant Auditory Hallucinations in Schizophrenia

Treatment-resistant Schizophrenia Clinical Trial

Official title:
Emotion Regulation Using Virtual Reality in Schizophrenia: a Clinical and Mechanistic Trial of Avatar Therapy for Refractory Auditory Hallucinations

Clinical Trial Summary

Treatment of verbal hallucinations in schizophrenia is clinically challenging for both the patient and the therapist. For the therapist, one of the main difficulties arises from the impossibility of directly communicating with the entity persecuting the patient. For the patient, the therapeutic process is challenging because it aims at getting to better cope with an entity that keeps repeating stereotyped and abusive sentences without having the emotional strength to reply to the persecutor. To help overcome these clinical challenges, virtual reality enable patients to recreate the face and the voice of their persecutor.The hypothesis is that the engagement of patients in a dialogue with an external representation of their persecutor, with the support of the therapist, would help them to gain better control over their voices.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03148639
Study type Interventional
Source Ciusss de L'Est de l'Île de Montréal
Contact
Status Completed
Phase N/A
Start date September 1, 2015
Completion date December 2, 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT03076346 - Neural Biomarkers of Clozapine Response
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Recruiting NCT06270108 - The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia Early Phase 1
Not yet recruiting NCT06060886 - Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis Phase 4
Recruiting NCT05694000 - Hippocampus DBS in Treatment-resistant Schizophrenia N/A
Completed NCT01105481 - Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients Phase 4
Recruiting NCT02361554 - Deep Brain Stimulation in Treatment Resistant Schizophrenia N/A
Recruiting NCT05299749 - Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations N/A
Completed NCT03585127 - Avatar Therapy in Comparison to Cognitive Behavioral Therapy for Treatment-resistant Schizophrenia N/A
Not yet recruiting NCT05259306 - Low-Intensity Focused Ultrasound Neuromodulation of the Mediodorsal Thalamus for Treatment-Resistant Schizophrenia N/A
Terminated NCT03230864 - Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia Phase 3
Recruiting NCT05337904 - Deep Brain Stimulation Recovery in Treatment-Resistant Schizophrenia N/A
Terminated NCT03868839 - Telmisartan Pilot Study on Treatment Resistant Schizophrenia Phase 2
Not yet recruiting NCT04528095 - SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia Phase 3
Not yet recruiting NCT06128408 - The Characteristics of Treatment Resistant Schizophrenia From the Illness Onset
Recruiting NCT05074732 - Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study.
Completed NCT03983018 - Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019) Phase 1
Recruiting NCT05741502 - An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine Phase 4
Recruiting NCT04054778 - Comparaison of Avatar Therapy to Cognitive Behavioral Therapy in Schizophrenia With Treatment Refractory Hallucinations N/A